New Generation Vaccine Adjuvants

This publication has 13 references indexed in Scilit:

• Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates
  The Journal of Experimental Medicine, 2006
• An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine
  Vaccine, 2006
• Adjuvant Activity of CpG Oligodeoxynucleotides
  International Reviews of Immunology, 2006
• Cross‐Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59‐Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy
  The Journal of Infectious Diseases, 2005
• Aluminium adjuvants—in retrospect and prospect
  Vaccine, 2004
• Promotion of B Cell Immune Responses via an Alum-Induced Myeloid Cell Population
  Science, 2004
• Recent advances in the discovery and delivery of vaccine adjuvants
  Nature Reviews Drug Discovery, 2003
• Toll-like receptors and innate immunity
  Nature Reviews Immunology, 2001
• Comparison of three different influenza vaccines in institutionalised elderly
  Vaccine, 2001
• CpG motifs in bacterial DNA trigger direct B-cell activation
  Nature, 1995